These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9226696)

  • 21. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating lymphocyte subpopulations and activated T and B cells in patients with chagasic and non-chagasic myocardiopathy.
    Piedras J; Gutierrez S; Reyes-López PA; Reyes K; López-Karpovitch X; Monteón V
    Cytometry; 1997 Feb; 30(1):28-32. PubMed ID: 9056739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific and non-specific lymphocyte blastogenic responses in individuals infected with Trypanosoma cruzi.
    Gusmão RD; Rassi A; Rezende JM; Neva FA
    Am J Trop Med Hyg; 1984 Sep; 33(5):827-34. PubMed ID: 6207739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody and lymphoblastogenic responses of dogs experimentally infected with Trypanosoma cruzi isolates from North American mammals.
    Barr SC; Dennis VA; Klei TR; Norcross NL
    Vet Immunol Immunopathol; 1991 Sep; 29(3-4):267-83. PubMed ID: 1949589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells.
    Costa RP; Gollob KJ; Fonseca LL; Rocha MO; Chaves AC; Medrano-Mercado N; Araújo-Jorge TC; Antas PR; Colley DG; Correa-Oliveira R; Gazzinelli G; Carvalho-Parra J; Dutra WO
    Scand J Immunol; 2000 May; 51(5):511-9. PubMed ID: 10792844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease.
    de Barros-Mazon S; Guariento ME; da Silva CA; Coffman RL; Abrahamsohn IA
    Clin Immunol; 2004 Apr; 111(1):137-45. PubMed ID: 15093563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection.
    Curotto de Lafaille MA; Barbosa de Oliveira LC; Lima GC; Abrahamsohn IA
    Exp Parasitol; 1990 Feb; 70(2):164-74. PubMed ID: 2105229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
    Sztein MB; Kierszenbaum F
    Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural CD4(+) T-cell responses against Trypanosoma cruzi KMP-11 protein in chronic chagasic patients.
    Cuellar A; Rojas F; Bolaños N; Diez H; Del Carmen Thomas M; Rosas F; Velasco V; López MC; González JM; Puerta C
    Immunol Cell Biol; 2009 Feb; 87(2):149-53. PubMed ID: 18957935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon- or interleukin-10 production is induced by related Trypanosoma cruzi antigens.
    Cuna WR; Encina JL; Cuna CR
    J Parasitol; 2000 Apr; 86(2):295-9. PubMed ID: 10780548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.
    Chaves AT; de Assis Silva Gomes Estanislau J; Fiuza JA; Carvalho AT; Ferreira KS; Fares RC; Guimarães PH; de Souza Fagundes EM; Morato MJ; Fujiwara RT; da Costa Rocha MO; Correa-Oliveira R
    BMC Infect Dis; 2016 Apr; 16():191. PubMed ID: 27138039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago.
    Bahia-Oliveira LM; Gomes JA; Cançado JR; Ferrari TC; Lemos EM; Luz ZM; Moreira MC; Gazzinelli G; Correa-Oliveira R
    J Infect Dis; 2000 Aug; 182(2):634-8. PubMed ID: 10915103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes.
    Kierszenbaum F; Moretti E; Sztein MB
    Immunology; 1991 Oct; 74(2):317-22. PubMed ID: 1748480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.
    Gomes JA; Molica AM; Keesen TS; Morato MJ; de Araujo FF; Fares RC; Fiuza JA; Chaves AT; Pinheiro V; Nunes Mdo C; Correa-Oliveira R; da Costa Rocha MO
    Hum Immunol; 2014 Jan; 75(1):20-8. PubMed ID: 24071371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferation and bystander suppression induced by membrane and flagellar antigens of Trypanosoma cruzi.
    Mosca W; Briceño L
    Invest Clin; 2009 Mar; 50(1):77-87. PubMed ID: 19418729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodological approach to the ex vivo expansion and detection of T. cruzi-specific T cells from chronic Chagas disease patients.
    Acevedo GR; Longhi SA; Bunying A; Sabri N; Atienza A; Zago MP; Santos R; Judkowski VA; Pinilla C; Gómez KA
    PLoS One; 2017; 12(5):e0178380. PubMed ID: 28552984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benznidazole: Hero or villain of cellular immune response in chronic Chagas disease patients?
    Soares AKA; Neves PAF; Nascimento AV; Esmeraldo AAM; Moreira LR; Higino TMM; C B Q Figueiredo R; G A M Cavalcanti M; Martins SM; Carrazone C; Júnior WO; Gomes YM; Lorena VMB
    Immunobiology; 2021 Jan; 226(1):152046. PubMed ID: 33341661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.